Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Opening Keynote: The Future of Rare Disease Trials AI-Driven Patient Identification and Recruitment
Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Opening Keynote: The Future of Rare Disease Trials AI-Driven Patient Identification and Recruitment
